Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT: NCT05785832 · COMPLETED

NCT IDNCT05785832
StatusCOMPLETED
Start Date2023-06-01
Completion2024-09-24
SponsorTandem Diabetes Care, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑